explore -WSS

explore

author：comprehensive 2025-09-29 18:17:57 - browse：59

insulin biosimilar — The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. Jacquelyn Martin/AP

A group representing clinical labs across the country sued the Food and Drug Administration on Wednesday over the agency’s plan to actively regulate lab-developed tests.

The suit, filed in a Texas federal court by the American Clinical Laboratory Association and PCR lab HealthTrackRx, claims the FDA does not have the authority to scrutinize lab-developed tests. When the FDA finalized its test regulation plan last month, several experts said it was only a matter of time until someone in the lab industry sued.

Tests made in labs have historically gone unregulated by the FDA, as the agency considered them low-risk when it started regulating medical devices in 1976. But the tests have since become more numerous and complex, and the regulatory gray area enabled unreliable tests to thrive and harm patients. Infamous examples include Theranos’ blood tests, as well as misleading prenatal genetic tests from a range of companies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： How a billionaire couple greased the skids for Pelosi’s drug pricing bill

hotspot

knowledge

WSS

Readers respond to H5N1 and livestock movements, and more

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

AI generated plenty of interest at JPM but not a lot of trust

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Can we make enough H5N1 bird flu vaccine if there's a pandemic?

Copay coupons to count toward deductibles, after Biden court move

entertainment

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

explore

Psychedelics group wrestles with new pharma identity

HIV vaccine remains elusive. Immunologists keep trying new ideas

Hollywood unions extend contract negotiations for actors

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

In Memoriam: Notable people who died in 2023

What to make of Gilead’s Trodelvy troubles and Elevation Oncology’s rise

Peter Hotez and the public health issue of online harassment

Cytokinetics CEO stresses company can launch heart drug on its own

Medical leaders decry Supreme Court decision on affirmative action

Big Tobacco's 'harm reduction': Is it for real, or a sham?

hotspot

Parkinson’s finding may lead to tests and, someday, treatments

Research misconduct: Proposed new rules face resistance

Second House panel advances two

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Bird flu: Don't repeat Covid's 'health versus the economy' framing

Venture capitalist Bob Kocher on the state of digital health

hotspot

Wikipedia

knowledge

explore